213 related articles for article (PubMed ID: 15367254)
1. Portfolio theory and cost-effectiveness analysis: a further discussion.
Sendi P; Al MJ; Rutten FF
Value Health; 2004; 7(5):595-601. PubMed ID: 15367254
[TBL] [Abstract][Full Text] [Related]
2. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
Sendi P; Al MJ; Gafni A; Birch S
Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
[TBL] [Abstract][Full Text] [Related]
3. Portfolio evaluation of health programs: a reply to Sendi et al.
Bridges JF; Terris DD
Soc Sci Med; 2004 May; 58(10):1849-51. PubMed ID: 15020002
[TBL] [Abstract][Full Text] [Related]
4. Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations.
Sendi P; Al MJ; Gafni A; Birch S
Soc Sci Med; 2004 May; 58(10):1853-5. PubMed ID: 15020003
[TBL] [Abstract][Full Text] [Related]
5. Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules.
O'Brien BJ; Sculpher MJ
Med Care; 2000 May; 38(5):460-8. PubMed ID: 10800973
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.
Sendi P; Al MJ
Soc Sci Med; 2003 Sep; 57(6):969-74. PubMed ID: 12878098
[TBL] [Abstract][Full Text] [Related]
7. Optimal investment in a portfolio of HIV prevention programs.
Zaric GS; Brandeau ML
Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
[TBL] [Abstract][Full Text] [Related]
8. Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.
Al MJ; Feenstra TL; Hout BA
Health Econ; 2005 Jul; 14(7):655-67. PubMed ID: 15678518
[TBL] [Abstract][Full Text] [Related]
9. A risk-adjusted approach to comparing the return on investment in health care programs.
Sendi P; Al MJ; Zimmermann H
Int J Health Care Finance Econ; 2004 Sep; 4(3):199-210. PubMed ID: 15277778
[TBL] [Abstract][Full Text] [Related]
10. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
Al MJ; Feenstra T; Brouwer WB
Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
[TBL] [Abstract][Full Text] [Related]
11. Application of cost-effectiveness analysis to multiple products: a practical guide.
Bala MV; Zarkin GA
Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
13. Ramsey waits: allocating public health service resources when there is rationing by waiting.
Gravelle H; Siciliani L
J Health Econ; 2008 Sep; 27(5):1143-54. PubMed ID: 18468707
[TBL] [Abstract][Full Text] [Related]
14. Opportunity costs and uncertainty in the economic evaluation of health care interventions.
Sendi P; Gafni A; Birch S
Health Econ; 2002 Jan; 11(1):23-31. PubMed ID: 11788979
[TBL] [Abstract][Full Text] [Related]
15. Optimal Allocation of Research Funds under a Budget Constraint.
Fairley M; Cipriano LE; Goldhaber-Fiebert JD
Med Decis Making; 2020 Aug; 40(6):797-814. PubMed ID: 32845233
[No Abstract] [Full Text] [Related]
16. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
Elbasha EH
Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
[TBL] [Abstract][Full Text] [Related]
17. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale.
Elbasha EH; Messonnier ML
Health Econ; 2004 Jan; 13(1):21-35. PubMed ID: 14724891
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis and capital costs.
Karlsson G; Johannesson M
Soc Sci Med; 1998 May; 46(9):1183-91. PubMed ID: 9572608
[TBL] [Abstract][Full Text] [Related]
20. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
Phillips KA; Hotlgrave DR
Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
